I wonder who bought COO shares in the open market, they are not small quantity.

True. Penta used to have a lot of negative comments when it was below 50 sens few years ago.

It is normal to see volume shrink when forming falling wedge. I don't consider K1 is laggard. Don't lost hope. Investment or trading need patience if you want to survive in the market.

K1 is forming a falling wedge. Not to worry. Just need to be patient.

For K1 business wise, it is moving in right direction for transforming from mobile accessories business into medical technology and cloud business. Once these sectors perform as per expected, the share price will improve. Just be patient.

The contribution of the manufacturing revenue is not depended on nasal swap or ventilator, so no need to harp on them.

I think the sales for nasal swap might be low or the profit margin is not much as it is not something so complicated to make.

Not sure about that. May be the sales from the nasal swap didn't contribute much. Anyway, i am interested in the GAP as the profit margin is higher. Hope they will expand more in this sector.

Yeap, the syringe cap shall also be contributed by next year. So next quarter results should be better.

I invested in K1 because of GAP.

I know, this is the price they for acquired GAP.

Chart wise, K1 is still very bearish, so I won't expect it will have a strong rebound until next quarter.

James, I am not worry about what they said because they contradicted with what I read from the K1 financial report. I am just very curious to know where us the disconection. Since Lalam2017 said he knows insider in K1. It is good to learn from him.

I can't get it, some of you keep saying no or zero sales before the last quarter result was out. , but when the result was out, the manufacturing sectors showed 16 millions sales or revenue. This 16 millions if not sales then what is it. And what contribute to this figure since he knows the company inside out. Btw, every quarter, there was revenue recorded in it financial statement. Not zero.

We know that the vaccine is just a MOU and it is not in the pipeline yet, how do you know that there is no sales from the rest? Where was the 36k coming from? I read through the report again and again but could not find the details. Can you pls let me know how they get the 36k since you have friends working there.

Lalam2017 In K1 latest quarterly report, for the manufacturing sector they have made 36k profit. Since you have repeatedly saying that they have no sales. May be I don't know how to read their financial report, can you pls explain how this figure coming from? Looking forward to learn from you.

Looks good as MI has expanded to related upstream business. This may further strengthen MI future earnings

Can't go lower than RM3.65. As this is the issued price of the new shares for Accurus Scientific Co Ltd. shareholders.

打底是須要時間和耐心的。

@gwiyomi 我也有同感。

It might consolidate until next quarter result is out.

Manufacturing is contributed about 70% of the sales ,whereas Cloud is contributed about 30%. It is near zero probability with zero sales.

Yes , great. Bonus issue plus warrants

IMO, no need to have pessimistic view on the cancellation of project, if there is. K1 is not a debt laden company, this show that the management is prudent in managing the company. Any cancellation of the project , I believe the management will replace by new businesses.

In November 2020, GAP via its wholly-owned subsidiary, G-AsiaPacific (S) Pte. Ltd. had secured
a major new customer based in Singapore. GAP will be providing cloud services with contract
value of approximately RM10 million per year for 3 years ie total of RM30 million commencing
December 2020. The said customer is one of the leading stock photo companies in the world. With
a well known customer in Singapore, it shall act as a good reference to grow the Group’s Cloud
business in Singapore in the near future.

Wait for this to contribute to the bottom line, next year.

https://www.klsescreener.com/v2/news/view/765841
The only thing did not mention in today article is the vaccine.

If it is about the cancellation of the project with Vaxine, it will be good for K1. It is too late for phase 2 trial as other vaccines like Pfizer-BioNTech covid 19 vaccines has been approved. No one will want to take part in the trial.

It is easy for us to critic the counter but it is not easy for the captain of the company to open new roads into China. I noticed that this CEO is very open and approachable to the shareholders. Given a choice, I prefer this type of CEO than the reclusive one.

Or 4) Accumulation is taking place.

Look for breakout in these few days , hopefully is Up.

Yes , good result. Now is to wait for the next catalyst i.e., transfer to main board and hope that SLVEST will secure more projects with the launch of LSS@MenTARI.

https://youtu.be/0VP2ywAAJbI

Yeap, invest wisely with our hard earned money.

Finally it is on its way up, weekly chart already turned bullish

@nolimitrade being positive will lead you further in life.

Hi Papayasshot, for those listed companies directly involved in solar solution provider in Bursa, which are profitable and doing well so far, are Cypark and SLVEST. SLVEST is among the first batch of grid tied solar installation providers that obtained the certificate from SEDA, ISPQ and GCPV in Malaysia.

The global direction is going for green energy and solar technology is the cheapest and the most profitable renewable sourse available. As Solarvest is a leader in this area, its future is great.
IMO, There is one project which made it stand out. It has installed and commissioned the largest floating solar farm in selangor. This is the latest trend in solar technology as it can save space. https://www.thesundaily.my/business/malaysia-s-largest-floating-solar-power-plant-comes-onstream-FH4458315
Hence it is worth to invest.

You are welcome @TreeTopView. Let's hope SLVest will shine soon.

https://focusmalaysia.my/markets/the-sun-to-continue-shining-brightly-on-solarvest/

Another remarkable quarterly result.

https://www.thesundaily.my/business/solarvest-to-harness-power-of-opensys-online-platform-buysolar-FK4941061

True , let's wait and see how these events play out.

@TreeTopView, you could be right on on the deduction of the private placement price at RM 1.30. If that is the case , current share price for SLVEST is a good discount to add already.

Yeah, they can't hold the price forever.

Common sense tells me buy and hold

Slvest share price is stagnant for the time being until the private placement price is fixed.

A company with net cash and with the management getting more new businesses in health care, should have no worries.

You might able to get it , they won't let the share price to go up so soon.

Continue to wait and see what games they are playing.

對。

The recent announcements by the company already gave out a lot of tips.